Accelerating clinical trials using machine learning

This past 12 months has been something of a challenge for us all – with everyone essentially living in limbo waiting for medical research to discover a treatment or prevention strategy for a brand-new disease. At the recent CES show, Charles Fisher, CEO, Unlearn.AI, discussed the role of machine learning in bringing cures for diseases such as COVID-19 to the market faster.